Published in Arch Intern Med on July 10, 2000
Fat distribution in men with HIV infection. J Acquir Immune Defic Syndr (2005) 4.02
Fat distribution in women with HIV infection. J Acquir Immune Defic Syndr (2006) 2.15
The associations of regional adipose tissue with lipid and lipoprotein levels in HIV-infected men. J Acquir Immune Defic Syndr (2008) 1.94
Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol (2013) 1.57
The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling. J Clin Invest (2004) 1.45
Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks. AIDS Res Hum Retroviruses (2012) 1.35
The prevalence and risk factors for abnormal liver enzymes in HIV-positive patients without hepatitis B or C coinfections. Dig Dis Sci (2007) 1.33
Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis (2005) 1.22
Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186. J Acquir Immune Defic Syndr (2008) 1.15
Health-related quality of life in veterans and nonveterans with HIV/AIDS. J Gen Intern Med (2006) 1.13
Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling study. PLoS One (2013) 1.11
Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy. HIV Med (2008) 1.10
Metabolic complications and treatment of perinatally HIV-infected children and adolescents. J Int AIDS Soc (2013) 1.09
Risk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort study. PLoS One (2012) 1.08
Evaluation and management of dyslipidemia in patients with HIV infection. J Gen Intern Med (2002) 1.04
Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood. Metabolism (2010) 1.03
Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children. BMC Infect Dis (2008) 1.02
Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial. J Clin Endocrinol Metab (2011) 1.00
Leptin and Adiponectin in the HIV Associated Metabolic Syndrome: Physiologic and Therapeutic Implications. Am J Infect Dis (2006) 1.00
Abnormal glucose metabolism among older men with or at risk of HIV infection. HIV Med (2006) 0.97
Metabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional survey. BMC Public Health (2013) 0.96
Prevalence and incidence of diabetes in HIV-infected minority patients on protease inhibitors. J Natl Med Assoc (2005) 0.95
Antiretroviral therapy in the clinic. J Virol (2010) 0.95
Focus on the heart: alcohol consumption, HIV infection, and cardiovascular disease. Alcohol Res Health (2010) 0.91
Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice. Antiviral Res (2010) 0.91
Long-term treatment with lopinavir-ritonavir induces a reduction in peripheral adipose depots in mice. Antimicrob Agents Chemother (2006) 0.90
Psychiatric and neurophysiological predictors of obesity in HIV/AIDS. Psychophysiology (2008) 0.88
Hepatitis C virus infection is associated with insulin resistance among older adults with or at risk of HIV infection. AIDS (2007) 0.87
Metabolic Abnormalities Associated with the Use of Protease Inhibitors and Non-nucleoside Reverse Transcriptase Inhibitors. Am J Infect Dis (2006) 0.87
Protease Inhibitors for Patients With HIV-1 Infection: A Comparative Overview. P T (2011) 0.86
Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020A. Pediatr Infect Dis J (2015) 0.86
Effects of the human immunodeficiency virus-protease inhibitor, ritonavir, on basal and catecholamine-stimulated lipolysis. J Clin Endocrinol Metab (2005) 0.86
Leptin in relation to the lipodystrophy-associated metabolic syndrome. Diabetes Metab J (2012) 0.85
Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients. Metabolism (2013) 0.83
Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeks. AIDS Patient Care STDS (2011) 0.82
Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment. Metabolism (2010) 0.82
Direct interference of HIV protease inhibitors with pancreatic beta-cell function. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.82
Acquired immunodeficiency syndrome in older African Americans. J Natl Med Assoc (2002) 0.81
Brain injury caused by HIV protease inhibitors: role of lipodystrophy and insulin resistance. Antiviral Res (2012) 0.81
Interactive effects of HIV/AIDS, body mass, and substance abuse on the frontal brain: a P300 study. Psychiatry Res (2010) 0.80
Lipoatrophy and lipohypertrophy are independently associated with hypertension. HIV Med (2009) 0.80
Polymorphisms in Fas gene is associated with HIV-related lipoatrophy in Thai patients. AIDS Res Hum Retroviruses (2012) 0.80
Prevalence of Dyslipidemia Among Antiretroviral-Naive HIV-Infected Individuals in China. Medicine (Baltimore) (2015) 0.80
Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients. BMC Infect Dis (2003) 0.78
Risk factors for new-onset diabetes mellitus in patients receiving protease inhibitor therapy. Can J Infect Dis Med Microbiol (2005) 0.78
Characteristics of HIV infection/AIDS in Korea. Korean J Intern Med (2001) 0.78
Predictors of insulin resistance among Hispanic adults infected with or at risk of infection with the human immunodeficiency virus and hepatitis C virus. J Viral Hepat (2008) 0.77
Lipid changes in Kenyan HIV-1-infected infants initiating highly active antiretroviral therapy by 1 year of age. Pediatr Infect Dis J (2013) 0.76
Pilot study on the safety and tolerability of extended release niacin for HIV-infected patients with hypertriglyceridemia. Hawaii Med J (2010) 0.76
Rhabdomyolysis: a case study exploring the possible side effect of lipid lowering medication by a HIV positive patient taking a protease inhibitor. J Can Chiropr Assoc (2008) 0.76
Cutis Verticis Gyrata in Men Affected by HIV-Related Lipodystrophy. Dermatol Res Pract (2013) 0.75
Cardiovascular disease risk scores' relationship to subclinical cardiovascular disease among HIV-infected and HIV-uninfected men. AIDS (2016) 0.75
Changes in lipid profiles after switching to a protease inhibitor-containing cART--unfavourable effect of fosamprenavir in obese patients. Eur J Med Res (2011) 0.75
Role of microRNA biogenesis in adipocyte and lipodystrophy. Adipocyte (2015) 0.75
Maternal placental syndromes among women living with HIV in Ontario: a population-based study. CMAJ Open (2015) 0.75
Moderate endurance training (marathon-training) - effects on immunologic and metabolic parameters in HIV-infected patients: the 42 KM cologne project. BMC Infect Dis (2017) 0.75
Role of leptin in the neuroendocrine response to fasting. Nature (1996) 8.02
ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results. AIDS (2001) 3.35
The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir Ther (2000) 3.14
Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med (1997) 2.73
Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa. Clin Infect Dis (1999) 1.83
Molecular epidemiology of acquisition of ceftazidime-resistant gram-negative bacilli in a nonoutbreak setting. J Clin Microbiol (1997) 1.82
Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women. Proc Natl Acad Sci U S A (1998) 1.39
Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011. Clin Infect Dis (2012) 1.36
Pseudo-Cushing's syndrome in human immunodeficiency virus-infected patients. Clin Infect Dis (1998) 1.36
IGF-I and IGF-II in relation to colorectal cancer. Int J Cancer (1999) 1.32
Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1993) 1.27
Intra-abdominal Candida infection during acute necrotizing pancreatitis has a high prevalence and is associated with increased mortality. Crit Care Med (1998) 1.20
Failure of quality control measures to prevent reporting of false resistance to imipenem, resulting in a pseudo-outbreak of imipenem-resistant Pseudomonas aeruginosa. J Clin Microbiol (1998) 1.16
Comparison of pulsed-field gel electrophoresis and amplified fragment-length polymorphism for epidemiological investigations of common nosocomial pathogens. Infect Control Hosp Epidemiol (2001) 1.15
The natural course of non-functioning pituitary macroadenomas. Eur J Endocrinol (2007) 1.12
Sex differences in circulating human leptin pulse amplitude: clinical implications. J Clin Endocrinol Metab (1998) 1.12
Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy. J Infect Dis (2001) 1.12
The molecular and clinical epidemiology of enterobacteriaceae-producing extended-spectrum beta-lactamase in a tertiary care hospital. J Infect (1998) 1.11
Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. J Clin Oncol (1999) 1.10
Insulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men. Int J Cancer (2000) 1.06
Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun (1995) 1.05
[The short version of the Brief Symptom Inventory (BSI -18): preliminary psychometric properties of the German translation]. Fortschr Neurol Psychiatr (2011) 1.05
Sources of disseminated Mycobacterium avium infection in AIDS. J Infect (2002) 1.05
Stabilities of free and complexed human immunodeficiency virus p24 antigens during short- and long-term storage. J Clin Microbiol (1997) 1.05
Decreased serum leptin in bulimia nervosa. J Clin Endocrinol Metab (2000) 1.03
Simplified surveillance for nosocomial bloodstream infections. Infect Control Hosp Epidemiol (1998) 1.03
Use of relational database management system by clinicians to create automated MICU progress note from existent data sources. Proc AMIA Annu Fall Symp (1997) 0.98
Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes. Diabetologia (2009) 0.97
Insulin-like growth factor-I and binding protein-3 in relation to childhood leukaemia. Int J Cancer (1999) 0.95
Barriers to bicycle helmet use among Dutch paediatricians. Child Care Health Dev (2008) 0.95
Measuring quality of life in early HIV disease: the modular approach. Qual Life Res (1997) 0.93
Phase I study of a human monoclonal antibody directed against the CD4-binding site of HIV type 1 glycoprotein 120. AIDS Res Hum Retroviruses (1998) 0.92
Dysphotopsia in phakic and pseudophakic patients: incidence and relation to intraocular lens type(2). J Cataract Refract Surg (2000) 0.90
The extent of non-adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker. AIDS (1998) 0.90
Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials Group. AIDS Res Hum Retroviruses (2000) 0.89
Isokinetic muscle performance in healthy female handball players and players with a unilateral anterior cruciate ligament reconstruction. Scand J Med Sci Sports (1996) 0.89
Performance enhancing drugs (doping agents) and sudden death--a case report and review of the literature. Int J Legal Med (1998) 0.86
Pharmacokinetics of F105, a human monoclonal antibody, in persons infected with human immunodeficiency virus type 1. Clin Pharmacol Ther (1996) 0.85
Interaction of fluorescence labeled single-stranded DNA with hexameric DNA-helicase RepA: a photon and fluorescence correlation spectroscopy study. Biochemistry (2001) 0.85
Endogenous risk factors for childhood leukemia in relation to the IGF system (Greece). The Childhood Haematologists-Oncologists Group. Cancer Causes Control (2000) 0.85
Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release. Br J Pharmacol (1997) 0.84
Serum steroid hormone levels, sex hormone-binding globulin, and body mass index in the etiology of postmenopausal breast cancer. Epidemiology (1996) 0.83
Toxoplasmosis in Sand cats (Felis margarita) and other animals in the Breeding Centre for Endangered Arabian Wildlife in the United Arab Emirates and Al Wabra Wildlife Preservation, the State of Qatar. Vet Parasitol (2010) 0.83
Scaling-up NLP Pipelines to Process Large Corpora of Clinical Notes. Methods Inf Med (2015) 0.83
Functional characterisation of MeCP2 mutations found in male patients with X linked mental retardation. J Med Genet (2002) 0.82
Effects of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene on the cellular levels of epoxide hydratase, cytochrome P-450b, and NADPH-cytochrome c (P-450) oxidoreductase messenger ribonucleic acids. J Biol Chem (1982) 0.81
Spatial patterns of mitochondrial and nuclear gene pools in chamois (Rupicapra r. rupicapra) from the Eastern Alps. Heredity (Edinb) (2003) 0.81
Interocular equality of tonic accommodation and consensuality of accommodative hysteresis. Ophthalmic Physiol Opt (1987) 0.80
Comparison of gynecologic history and laboratory results in HIV-positive women with CD4+ lymphocyte counts between 200 and 500 cells/microl and below 100 cells/microl. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.79
Can a regular leg extension bench be used in testing deficits of the quadriceps muscle during rehabilitation? Scand J Med Sci Sports (1995) 0.79
Procalcitonin: a new marker for diagnosis of acute rejection and nonviral infection of heart and lung transplant patients. Transplant Proc (2001) 0.78
Efficient trial designs for studying combination antiretroviral treatments in patients with various resistance profiles. J Infect Dis (1998) 0.78
Testosterone metabolism in human skin cells in vitro and its interaction with estradiol and dutasteride. Skin Pharmacol Appl Skin Physiol (2003) 0.78
Molecular epidemiology of ceftazidime-resistant gram-negative bacilli on inanimate surfaces and their role in cross-transmission during nonoutbreak periods. J Clin Microbiol (1999) 0.78
The influence of smoking habits on thyroid gland volume: an ultrasonic approach. J R Soc Health (1997) 0.78
Estrogens, testosterone and sex hormone binding globulin in relation to liver cancer in men. Oncology (2001) 0.78
Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone. Am Rev Respir Dis (1977) 0.77
Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World. N Engl J Med (1998) 0.76
Surgical treatment of medial tibial stress syndrome (shin splint) by fasciotomy of the superficial posterior compartment of the leg. Scand J Med Sci Sports (1995) 0.76
Kinetics of nuclear translocation and turnover of the vitamin D receptor in human HL60 leukemia cells and peripheral blood lymphocytes--coincident rise of DNA-relaxing activity in nuclear extracts. J Steroid Biochem Mol Biol (1992) 0.76
Insulin-like growth factor binding protein-3 predicts survival from acute childhood leukemia. Oncology (2001) 0.75
AZT trial in Thailand. Science (1995) 0.75
Growth velocity during the first postnatal week of life is not related to adiponectin or leptin. Paediatr Perinat Epidemiol (2004) 0.75
[Meningoencephalitis listeriosa]. Orv Hetil (1971) 0.75
Accuracy of fluoroscopy in the treatment of intra-articular thumb metacarpal fractures. J Hand Surg Eur Vol (2012) 0.75
Virologic and CD4 cell response to zidovudine or zidovudine and lamivudine following didanosine treatment of human immunodeficiency virus infection. AIDS Res Hum Retroviruses (2001) 0.75
The efficiency of a new cell separation technique in bone marrow purging without damaging the purged tumor cells. Prog Clin Biol Res (1990) 0.75
[As time goes by--is it worth intensifying patient care during the waiting period for radiological examinations?]. Rofo (2012) 0.75
Transcriptional activity of potent glucocorticoids: relevance of glucocorticoid receptor isoforms and drug metabolites. Skin Pharmacol Appl Skin Physiol (2003) 0.75
Antiretroviral and immune-based therapies: update. AIDS (1993) 0.75
Perspective: human immunodeficiency virus type 1 (HIV-1) RNA end points in HIV clinical trials: issues in interim monitoring and early stopping. J Infect Dis (1998) 0.75
Percutaneous management of postoperative bile leaks with an ethylene vinyl alcohol copolymer (Onyx). Rofo (2013) 0.75
[The significance of atypical monocytes in tumorous and other diseases]. Orv Hetil (1968) 0.75
Pharmacy automation considerations. Comput Healthc (1987) 0.75
Perforation of the terminal ileum with cytomegalovirus vasculitis and Kaposi's sarcoma in a patient with acquired immunodeficiency syndrome. Surgery (1987) 0.75
Better business decisions today for tomorrow. Medical records and concurrent review. Healthc Comput Commun (1986) 0.75
To treat or not to treat--approaches to antiretroviral therapy. Interview by Anthony J. Japour. AIDS Clin Care (1996) 0.75
Utility of clinical symptoms versus laboratory tests for evaluation of acute gastroenteritis. Dig Dis Sci (1996) 0.75
Effects of dehydration and rehydration on plasma vasopressin and aldosterone in horses. Physiol Behav (1993) 0.75
Endocrinologic and psychological effects of short-term dexamethasone in anorexia nervosa. Eat Weight Disord (2000) 0.75